<DOC>
	<DOCNO>NCT01700244</DOCNO>
	<brief_summary>An evaluation safety performance new cardiac pacemaker</brief_summary>
	<brief_title>Evaluation New Cardiac Pacemaker</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Bradycardia</mesh_term>
	<mesh_term>Syncope</mesh_term>
	<criteria>Subject must one follow clinical indication : 1 . Chronic atrial fibrillation 2 3° AV bifascicular bundle branch block ( BBB block ) ; 2 . Normal sinus rhythm 2 3° AV BBB block low level physical activity short expect lifespan ( least one year ) ; 3 . Sinus bradycardia infrequent pause unexplained syncope EP finding ; Subject ≥18 year age ; Subject life expectancy least one year ; Subject enrol another clinical investigation ; Subject willing comply clinical investigation procedure agree return require followup visit , test , exam ; Subject inform nature study , agree provision provide write informed consent , approve EC ; If female , 3 month postoperative , subject actively practice contraception method , practice abstinence , surgically sterilize , postmenopausal . Pacemaker dependent ; Known pacemaker syndrome , retrograde VA conduction suffer drop arterial blood pressure onset ventricular pacing ; Hypersensitivity &lt; 1 mg dexamethasone sodium phosphate ; Mechanical tricuspid valve prosthesis ; Preexisting pulmonary arterial ( PA ) hypertension significant physiologicallyimpairing lung disease ; Preexisting pace defibrillation lead ; Current implantation implantable cardioverter defibrillator ( ICD ) cardiac resynchronization therapy ( CRT ) ; Presence implant vena cava filter ; Presence implant leadless cardiac pacemaker ; Pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>